NO910720L - Vektorer og forbindelser for ekspresjon av zymogene former av humant protein c. - Google Patents

Vektorer og forbindelser for ekspresjon av zymogene former av humant protein c.

Info

Publication number
NO910720L
NO910720L NO91910720A NO910720A NO910720L NO 910720 L NO910720 L NO 910720L NO 91910720 A NO91910720 A NO 91910720A NO 910720 A NO910720 A NO 910720A NO 910720 L NO910720 L NO 910720L
Authority
NO
Norway
Prior art keywords
humant
vectors
relationships
protein
expression
Prior art date
Application number
NO91910720A
Other languages
English (en)
Norwegian (no)
Other versions
NO910720D0 (no
Inventor
Bruce Edward Gerlitz
Brian William Grinnell
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO910720D0 publication Critical patent/NO910720D0/no
Publication of NO910720L publication Critical patent/NO910720L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6464—Protein C (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21069—Protein C activated (3.4.21.69)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
NO91910720A 1990-02-23 1991-02-22 Vektorer og forbindelser for ekspresjon av zymogene former av humant protein c. NO910720L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/484,133 US5270178A (en) 1990-02-23 1990-02-23 Vectors and compounds for expression of zymogen forms of human protein C

Publications (2)

Publication Number Publication Date
NO910720D0 NO910720D0 (no) 1991-02-22
NO910720L true NO910720L (no) 1991-08-26

Family

ID=23922892

Family Applications (1)

Application Number Title Priority Date Filing Date
NO91910720A NO910720L (no) 1990-02-23 1991-02-22 Vektorer og forbindelser for ekspresjon av zymogene former av humant protein c.

Country Status (17)

Country Link
US (1) US5270178A (fr)
EP (1) EP0443875A3 (fr)
JP (1) JPH05103678A (fr)
KR (1) KR910021476A (fr)
CN (1) CN1054798A (fr)
AU (1) AU7130891A (fr)
CA (1) CA2036915A1 (fr)
FI (1) FI910853A (fr)
HU (1) HUT61592A (fr)
IE (1) IE910610A1 (fr)
IL (1) IL97310A0 (fr)
MX (1) MX24652A (fr)
NO (1) NO910720L (fr)
NZ (1) NZ237198A (fr)
PT (1) PT96854A (fr)
YU (1) YU31791A (fr)
ZA (1) ZA911330B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL97312A (en) * 1990-02-23 1999-01-26 Lilly Co Eli A method of generating a polypeptide in an eukaryotic vector AND recombinant surrogate cell containing an enhanced transcriptional control unit based on the primary late adenovirus coefficient
IL97311A0 (en) * 1990-02-23 1992-05-25 Lilly Co Eli Vectors and compounds for expression of glycosylation mutants of human protein c
MY110664A (en) * 1992-05-21 1999-01-30 Lilly Co Eli Protein c derivatives
DE4320294A1 (de) * 1993-06-18 1994-12-22 Immuno Ag Verwendung von humanem Protein C zur Verhinderung und Behandlung von Thrombozytenablagerungen
US5585095A (en) * 1993-09-14 1996-12-17 Regents Of The University Of Minnesota Method to enhance thrombomodulin APC generation using cationic proteins
JP2002529515A (ja) * 1998-11-13 2002-09-10 イーライ・リリー・アンド・カンパニー ヘパリンにより誘発される血小板減少症の処置法
US6420157B1 (en) * 1999-04-30 2002-07-16 Ortho-Mcneil Pharmaceutical, Inc. Zymogen activation system
US6485957B1 (en) 1999-04-30 2002-11-26 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease EOS
US6998122B1 (en) * 1999-04-30 2006-02-14 Eli Lilly And Company Protein C derivatives
US6426199B1 (en) 1999-08-31 2002-07-30 Ortho-Mcneil Pharmaceutical, Inc. Dna
US6458564B1 (en) 1999-08-31 2002-10-01 Ortho-Mcneil Pharmaceutical, Inc. DNA encoding the human serine protease T
WO2001036462A2 (fr) * 1999-11-19 2001-05-25 Eli Lilly And Company Derives de proteine c
EP1255821B1 (fr) 2000-02-02 2004-12-29 Eli Lilly And Company Derives de proteine c
EP1263943A1 (fr) 2000-02-11 2002-12-11 Eli Lilly & Company Derives de la proteine c
EP1328622A2 (fr) * 2000-10-18 2003-07-23 Maxygen Aps Molecules de proteine c ou de type proteine c activee
US6933367B2 (en) 2000-10-18 2005-08-23 Maxygen Aps Protein C or activated protein C-like molecules
US20070142272A1 (en) * 2003-01-24 2007-06-21 Zlokovic Berislav V Neuroprotective activity of activated protein c independent of its anticoagulant activity
US20080305100A1 (en) * 2004-07-23 2008-12-11 Zlokovic Berislav V Activated Protein C Inhibits Undesirable Effects of Plasminogen Activator in the Brain
US20100041600A1 (en) * 2006-06-09 2010-02-18 Russel James A Interferon gamma polymorphisms as indicators of subject outcome in critically ill subjects
US20110171200A1 (en) * 2008-01-15 2011-07-14 Walley Keith R Protein c rs2069915 as a response predictor to survival and administration of activated protein c or protein c-like compound
WO2012068519A2 (fr) 2010-11-19 2012-05-24 Sirius Genomics Inc. Marqueurs associés à la réponse à une administration de la protéine c activée, et leurs utilisations
WO2023119230A1 (fr) 2021-12-22 2023-06-29 L'oreal Compositions de modulation de la voie de coagulation et de la voie de nicotinamide-adénine dinucléotide et leurs procédés d'utilisation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4775624A (en) * 1985-02-08 1988-10-04 Eli Lilly And Company Vectors and compounds for expression of human protein C
DE3688900T3 (de) * 1985-06-27 1998-06-10 Univ Washington Expression von Protein C.
EP0245949B1 (fr) * 1986-04-09 1997-10-29 Eli Lilly And Company Méthode d'utilisation des vecteurs d'expression eucaryotiques comportant les séquences stimulantes du virus BK
US4992373A (en) * 1987-12-04 1991-02-12 Eli Lilly And Company Vectors and compounds for direct expression of activated human protein C
ZA889497B (en) * 1987-12-28 1990-08-29 Lilly Co Eli Vectors and compounds for expression of zymogen forms of human protein c
CA1332049C (fr) * 1988-10-07 1994-09-20 Eli Lilly And Company Expression eucaryotique

Also Published As

Publication number Publication date
YU31791A (sh) 1994-05-10
HUT61592A (en) 1993-01-28
MX24652A (es) 1994-01-31
CN1054798A (zh) 1991-09-25
IE910610A1 (en) 1991-08-28
PT96854A (pt) 1991-10-31
HU910605D0 (en) 1991-09-30
JPH05103678A (ja) 1993-04-27
EP0443875A2 (fr) 1991-08-28
CA2036915A1 (fr) 1991-08-24
US5270178A (en) 1993-12-14
AU7130891A (en) 1991-08-29
KR910021476A (ko) 1991-12-20
FI910853A (fi) 1991-08-24
IL97310A0 (en) 1992-05-25
NO910720D0 (no) 1991-02-22
NZ237198A (en) 1993-07-27
ZA911330B (en) 1992-10-28
FI910853A0 (fi) 1991-02-22
EP0443875A3 (en) 1992-07-15

Similar Documents

Publication Publication Date Title
NO910720L (no) Vektorer og forbindelser for ekspresjon av zymogene former av humant protein c.
NO921863L (no) Antistoffer og anvendelse derav
DE68917323D1 (de) Expressions-Vektor für Fusions-Proteine und Immunogen-Proteine.
DK91192D0 (da) Protein
NO911915D0 (no) Slagloddingslegering og anvendelse av denne.
NO931138D0 (no) Omco-foetalt gen, genprodukt og anvendelse derav
DK450584A (da) Ekspressionsvektorer og anvendelse deraf til fremstilling af et protein med aktiviteten af humant antitrypsin-alfa1
DE69117266D1 (de) Modifizierung von gelatine
FI904708A0 (fi) Anordning foer kontrollerad foerbraenning av laettantaendlig vaete-luft-blandning i en kaernteknisk anlaeggning.
NO910773D0 (no) Koboltbasert knalegering og anvendelse av denne.
DE3852625D1 (de) Vektoren und Verbindungen zur Expression von Zymogen-Formen von menschlichem Protein C.
DE69120700D1 (de) Polypeptidepaar
NO881502L (no) Rekombinante htlv-111-proteiner og anvendelser av disse.
NO905001D0 (no) Anvendelse og bruk av spesielt magnetisk vektorpotensial for behandling av materialer.
DK75393D0 (da) Production of protein
NO914919L (no) Nikkelbasert superlegering og anvendelse av denne
DE69101849D1 (de) Herstellung von Amiden.
FI913285A (fi) Svavelsubstituerade mevinsyraderivat.
NO882836L (no) Fremgangsmaate for kjemisk modifisering av protider (proteiner og peptider).
DK251090D0 (da) Antistoffer og anvendelse deraf
FI904766A (fi) Foerfarande foer detektering av protein.
NO924995D0 (no) Humant meg-csf-protein og fremgangsmaater
NO901421D0 (no) Intranasal administrering av fysostigmin og arecolin.
NO881501D0 (no) Rekombinante htlv-111 proteiner og anvendelse av disse.
NO892961L (no) Skummateriale og anvendelse av dette.